AAAAAA
Results:
1-16
|
Results: 16
Authors:
DiTusa, L
Luzier, AB
Jarosz, DE
Snyder, BD
Izzo, JL
Citation: L. Ditusa et al., Treatment of hypertension in a managed care setting, AM J M CARE, 7(5), 2001, pp. 520-524
Authors:
Allen, K
Shykoff, BE
Izzo, JL
Citation: K. Allen et al., Pet ownership, but not ACE inhibitor therapy, blunts home blood pressure responses to mental stress, HYPERTENSIO, 38(4), 2001, pp. 815-820
Authors:
Izzo, JL
Citation: Jl. Izzo, Editorial commentary - Aging and systolic hypertension - Cluster patterns and problem-solving strategies to answer the genetic riddle, HYPERTENSIO, 37(4), 2001, pp. 1067-1068
Authors:
Chow, SL
Luzier, AB
DiTusa, L
Snyder, BD
Izzo, JL
Citation: Sl. Chow et al., Acid-suppressive therapy use associated with antihypertensive agents, J CLIN PHAR, 41(7), 2001, pp. 750-756
Authors:
Allen, K
Golden, LH
Izzo, JL
Ching, MI
Forrest, A
Niles, CR
Niswander, PR
Barlow, JC
Citation: K. Allen et al., Normalization of hypertensive responses during ambulatory surgical stress by perioperative music, PSYCHOS MED, 63(3), 2001, pp. 487-492
Authors:
Izzo, JL
Citation: Jl. Izzo, Selective alpha(1)-blockers, CUR CL PRAC, 2001, pp. 333-338
Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angiotensin system
Authors:
Izzo, JL
Citation: Jl. Izzo, Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angiotensin system, BL PRESS M, 5, 2000, pp. S7-S11
Authors:
Hollenberg, NK
Izzo, JL
Sica, DA
White, WB
Mansoor, GA
Citation: Nk. Hollenberg et al., Vascular disease and the renin-angiotensin system in the patient with hypertension: panel discussion and questions from the audience, BL PRESS M, 5, 2000, pp. S27-S29
Authors:
Izzo, JL
Levy, D
Black, HR
Citation: Jl. Izzo et al., Importance of systolic blood pressure in older Americans, HYPERTENSIO, 35(5), 2000, pp. 1021-1024
Authors:
Luzier, AB
Forrest, A
Feuerstein, SG
Schentag, JJ
Izzo, JL
Citation: Ab. Luzier et al., Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization, AM J CARD, 86(5), 2000, pp. 519-523
Authors:
Izzo, JL
Citation: Jl. Izzo, Changes in blood pressure and vascular physiology: Markers for cardiovascular disease, AM J M CARE, 5(12), 1999, pp. S712-S717
Authors:
Weber, MA
Safar, ME
Cohn, JN
Izzo, JL
Neutel, JM
Citation: Ma. Weber et al., Issues in vascular compliance, AM J M CARE, 5(12), 1999, pp. S738-S745
Authors:
Izzo, JL
Citation: Jl. Izzo, Risk stratification: A key to managing hypertension in the managed care setting, AM J M CARE, 5(12), 1999, pp. S746-S751
Authors:
Huang, MH
Knight, PR
Izzo, JL
Citation: Mh. Huang et al., Ca2+-induced Ca2+ release involved in positive inotropic effect mediated by CGRP in ventricular myocytes, AM J P-REG, 45(1), 1999, pp. R259-R264
Authors:
Sung, BH
Ching, M
Izzo, JL
Dandona, P
Wilson, MF
Citation: Bh. Sung et al., Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women, J HYPERTENS, 17(4), 1999, pp. 523-528
Authors:
Sung, BH
Izzo, JL
Dandona, P
Wilson, MF
Citation: Bh. Sung et al., Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus, HYPERTENSIO, 34(1), 1999, pp. 83-88
Risultati:
1-16
|